Skip to content
Search

Latest Stories

Virat Kohli named Leading Cricketer in the World for 2016 by Wisden

Indian skipper Virat Kohli has reached yet another milestone after the flamboyant right-hand batsman was named as the cricketer of the year for 2016. Kohli featured on the cover of 2017 edition of the Wisden Cricketers’ Almanack.

“Virat Kohli, who features on the cover of the 2017 edition of the Wisden Cricketers’ Almanack, is also the Leading Cricketer in the World for 2016, an accolade put in place in 2003 when Ricky Ponting became the first honouree,” Wisden announced.


Kohli smashed a total of four double hundreds in consecutive Test series and led India to series wins against New Zealand, England, West Indies, Australia and a one-off Test victory against Bangladesh. The cover picture shows the skipper going for a reverse sweep shot from one Test match and this is the second time that Kohli has been named the cricketer of the year in their 2017 edition.

Virat scored over 1200 runs in this Test season during the course of his team’s glorious runs in the longest format of the game while was handed over the captaincy reigns from MS Dhoni in the limited overs format too. Though, he had a superb run with the bat, the Indian skipper’s run-flow was brought to a halt during India’s four-match Test series against Australia.

In three matches that he played, Virat only managed to score 46 runs while sustained a shoulder injury during India’s third match in Ranchi after which he opted to be out of the fourth and final clash.

Presently, he has also been ruled out of the cash-rich Indian Premier League due to injury.

While Virat Kohli is named the leading Cricketer in the World, Ellyse Perry was named leading Woman Cricketer in the World. Misbah-ul-Haq, Younis Khan, Ben Duckett, Toby Roland-Jones, Chris Woakes were named the cricketres of the year.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less